Pharmacokinetics of tramadol and its three main metabolites in healthy male and female volunteers

被引:48
作者
Ardakani, Yalda H. [1 ]
Rouini, Mohammad-Reza [1 ]
机构
[1] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut, Biopharmaceut & Pharmacokinet Div, Tehran 141556451, Iran
关键词
D O I
10.1002/bdd.584
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
By using a high-performance liquid chromatography method, the pharmacokinetics of the tramadol (T) and its three main metabolites, O-desmethyltramadol (M1), N-desmethyltramadol (M2) and O,N-didesmethyltramadol (M5) was studied in healthy male and female Iranian volunteers after oral administration of two 50 mg tramadol hydrochloride tablets. The related pharmacokinetic parameters such as C-max, T-max, AUC((0-t)), AUC((0-infinity)) T-1/2 and Cl/F were calculated and compared between the two genders. No significant differences were found in the systemic exposure and pharmacokinetic of tramadol, M1 and M2 while there were significant differences in AUCs of M5 in the two genders. It was concluded that to get a more accurate result, the gender dependency of T and its metabolites might be studied in specific phenotypes. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 16 条
[1]   Concordance between tramadol and dextromethorphan parent/metabolite ratios: The influence of CYP2D6 and non-CYP2D6 pathways on biotransformation [J].
Abdel-Rahman, SM ;
Leeder, JS ;
Wilson, JT ;
Gaedigk, A ;
Gotschall, RR ;
Medve, R ;
Liao, S ;
Spielberg, SP ;
Kearns, GL .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (01) :24-29
[2]   Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype [J].
Garcia-Quetglas, Emilio ;
Ramon Azanza, Jose ;
Sadaba, Belen ;
Jose Munoz, Maria ;
Gil, Isabel ;
Angel Campanero, Miguel .
PHARMACOLOGICAL RESEARCH, 2007, 55 (02) :122-130
[3]  
Gibson Thomas P., 1996, American Journal of Medicine, V101, p47S
[4]   TRAMADOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN ACUTE AND CHRONIC PAIN STATES [J].
LEE, CR ;
MCTAVISH, D ;
SORKIN, EM .
DRUGS, 1993, 46 (02) :313-340
[5]  
Lintz W, 1998, ARZNEIMITTEL-FORSCH, V48, P436
[6]  
LINTZ W, 1981, ARZNEIMITTEL-FORSCH, V31-2, P1932
[7]   Pharmacokinetics of the enantiomers of trans-tramadol and its active metabolite, trans-O-demethyltramadol, in healthy male and female Chinese volunteers [J].
Liu, HC ;
Yu, Y ;
Wang, N ;
Deng, M ;
Liu, JF ;
Xue, HY .
CHIRALITY, 2004, 16 (02) :112-118
[8]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[9]   FREQUENCY-DISTRIBUTION OF DAPSONE N-HYDROXYLASE, A PUTATIVE PROBE FOR P4503A4 ACTIVITY, IN A WHITE-POPULATION [J].
MAY, DG ;
PORTER, J ;
WILKINSON, GR ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (05) :492-500
[10]   High-performance liquid chromatographic determination of tramadol and its O-desmethylated metabolite in blood plasma -: Application to a bioequivalence study in humans [J].
Nobilis, M ;
Kopecky, J ;
Kvetina, J ;
Chládek, J ;
Svoboda, Z ;
Vorísek, V ;
Perlík, F ;
Pour, M ;
Kunes, J .
JOURNAL OF CHROMATOGRAPHY A, 2002, 949 (1-2) :11-22